Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Haematologica

Volumn 93, Issue 11, 2008, Pages 1712-1717

  Mufti, Ghulam J ^a,q   Bennett, John M ^b   Goasguen, Jean ^c   Bain, Barbara J ^d   Baumann, Irith ^e   Brunning, Richard ^f   Cazzola, Mario ^g   Fenaux, Pierre ^h   Germing, Ulrich ⁱ   Hellström Lindberg, Eva ^j   Jinnai, Itsuro ^k   Manabe, Atsushi ^l   Matsuda, Akira ^k   Niemeyer, Charlotte M ^m   Sanz, Guillermo ⁿ   Tomonaga, Masao ^o   Vallespi, Teresa ^p   Yoshimi, Ayami ⁿ  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITÉ DE RENNES 1   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Medical Hospital   (Germany)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF PAVIA   (Italy)

^h UNIVERSITÉ PARIS 13   (France)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j KAROLINSKA INSTITUTE   (Sweden)

^k SAITAMA MEDICAL UNIVERSITY   (Japan)

^l ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^o NAGASAKI UNIVERSITY   (Japan)

^p HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^q KING S COLLEGE HOSPITAL   (United Kingdom)

more..

Author keywords

Myeloblast; Myelodysplastic syndrome; Ring sideroblast

Indexed keywords

BLAST CELL; CELL COUNT; CELL STRUCTURE; CONSENSUS; DISEASE CLASSIFICATION; ERYTHROBLAST; HUMAN; MYELOBLAST; MYELODYSPLASTIC SYNDROME; PROGNOSIS; PROMYELOCYTE; REVIEW;

ANEMIA, SIDEROBLASTIC; DECISION MAKING; EUROPE; GRANULOCYTE PRECURSOR CELLS; HUMANS; INTERNATIONAL COOPERATION; MYELODYSPLASTIC SYNDROMES; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 55549136382     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13405     Document Type: Review

References (16)

1. List AF, Vardiman J, Issa JP, DeWitte TM. Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2004:297-317.
2. Mufti G, List AF, Gore SD, Ho AY. Myelodysplastic syndrome. Hematology (Am Soc Hematol Educ Program) 2003:176-99.
3. John AM, Thomas NS, Mufti GJ, Padua RA. Targeted therapies in myeloid leukemia. Semin Cancer Biol 2004;14:41-62.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:89-99.
5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88.
6. IBID: Erratum. Blood 1998;91:1100.
7. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization. Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon 2001.
8. Malcovati L, Germing U, Kuendgen, A, Della Porta MG, Pascutto C, Invernizzi R, et al. Time dependent prognostic scoring system for predicting survival and leukemic evolution in the myelodysplastic syndromes. J Clin Oncol 2007;25:3503-10.
9. Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, et al. Minimal diagnostic criteria and differential diagnosis of MDS: IWGM-MDS consensus proposal for identification of idiopathic cytopenia of uncertain significance (ICUS). Paper presented at the 9th International Symposium on Myelodysplastic Syndromes, Florence, Italy, 2007.
10. Mufti GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 2004;17:543-57.
11. Komrokji RS, Bennett JM. Evolving classifications of the myelodysplastic syndromes. Curr Opin Hematol 2007;14:98-105.
12. Goasguen JE, Bennett J, Cox C, Hambley H, Mufti GJ, Flandrin G. Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome. Leuk Res 1991;15:1159-65.
13. Lehmann EL. Nonparametrics: statistical methods based on ranks. Berkeley, CA, USA. Holden-Dat, 1975.
14. Goasguen JE, Bennett JM, Bain B, Brunning R, Vallespi M-T, Cox C, Mufti GJ. New definitions for blast cells in AML and MDS with validation by virtual microscopy. Leuk Res 2007; 31:Suppl 1:S25.
15. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds). WHO Classification of tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon 2008.
16. Juneja SK, Imbert M, Jouault H, Scoazec JY, Sigaux F, Sultan C. Haematological features of patients with primary myelodysplastic syndromes at initial presentation: a study of 118 cases. J Clin Pathol 1983;36:1129-35.